Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.
Wang J, Bi W, Zhao W, Varghese M, Koch RJ, Walker RH, Chandraratna RA, Sanders ME, Janesick A, Blumberg B, Ward L, Ho L, Pasinetti GM.
Wang J, et al.
Oncotarget. 2016 Feb 16;7(7):7469-79. doi: 10.18632/oncotarget.7191.
Oncotarget. 2016.
PMID: 26862735
Free PMC article.